AAAAAA

   
Results: 1-17 |
Results: 17
Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli
Authors: Giakkoupi, P Hujer, AM Miriagou, V Tzelepi, E Bonomo, RA Tzouvelekis, LS
Citation: P. Giakkoupi et al., Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli, FEMS MICROB, 201(1), 2001, pp. 37-40
Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice
Authors: Donskey, CJ Hoyen, CK Das, SM Farmer, S Dery, M Bonomo, RA
Citation: Cj. Donskey et al., Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice, LETT APPL M, 33(1), 2001, pp. 84-88
Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization
Authors: Bonomo, RA Liu, JZ Chen, YH Ng, L Hujer, AM Anderson, VE
Citation: Ra. Bonomo et al., Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization, BBA-PROT ST, 1547(2), 2001, pp. 196-205
Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance
Authors: Hujer, AM Hujer, KM Bonomo, RA
Citation: Am. Hujer et al., Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance, BBA-PROT ST, 1547(1), 2001, pp. 37-50
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for the clinical microbiology laboratory
Authors: Paterson, DL Ko, WC Von Gottberg, A Casellas, JM Mulazimoglu, L Klugman, KP Bonomo, RA Rice, LB McCormack, JG Yu, VL
Citation: Dl. Paterson et al., Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for the clinical microbiology laboratory, J CLIN MICR, 39(6), 2001, pp. 2206-2212
Inhibition of the SHV-1 beta-lactamase by sulfones: Crystallographic observation of two reaction intermediates with tazobactam
Authors: Kuzin, AP Nukaga, M Nukaga, Y Hujer, A Bonomo, RA Knox, JR
Citation: Ap. Kuzin et al., Inhibition of the SHV-1 beta-lactamase by sulfones: Crystallographic observation of two reaction intermediates with tazobactam, BIOCHEM, 40(6), 2001, pp. 1861-1866
Multi-drug resistant organisms in long-term care facilities
Authors: Bonomo, RA Rice, LB
Citation: Ra. Bonomo et Lb. Rice, Multi-drug resistant organisms in long-term care facilities, INFEC DIS S, 2001, pp. 257-275
beta-lactamases: which ones are clinically important?
Authors: Rice, LB Bonomo, RA
Citation: Lb. Rice et Ra. Bonomo, beta-lactamases: which ones are clinically important?, DRUG RESIST, 3(3), 2000, pp. 178-189
Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases
Authors: Bonomo, RA
Citation: Ra. Bonomo, Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases, CLIN INF D, 31(6), 2000, pp. 1414-1422
Enterobacter species bacteremia: Factors predictive of mortality at a tertiary care institution
Authors: Bonomo, RA Fiorentino, M Salvatore, A Jacobs, M Morrisey, A Whalen, C Salata, RA
Citation: Ra. Bonomo et al., Enterobacter species bacteremia: Factors predictive of mortality at a tertiary care institution, INF DIS C P, 9(3), 2000, pp. 123-127
High-level expression of chromosomally encoded SHV-1 beta-lactamase and anouter membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae
Authors: Rice, LB Carias, LL Hujer, AM Bonafede, M Hutton, R Hoyen, C Bonomo, RA
Citation: Lb. Rice et al., High-level expression of chromosomally encoded SHV-1 beta-lactamase and anouter membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae, ANTIM AG CH, 44(2), 2000, pp. 362-367
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.
Authors: Donskey, CJ Chowdhry, TK Hecker, MT Hoyen, CK Hanrahan, JA Hujer, AM Hutton-Thomas, RA Whalen, CC Bonomo, RA Rice, LB
Citation: Cj. Donskey et al., Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients., N ENG J MED, 343(26), 2000, pp. 1925-1932
Neuroleptic malignant-like syndrome in an elderly patient caused by abruptwithdrawal of tolcapone, a catechol-O-methyl transferase inhibitor
Authors: Iwuagwu, CU Riley, D Bonomo, RA
Citation: Cu. Iwuagwu et al., Neuroleptic malignant-like syndrome in an elderly patient caused by abruptwithdrawal of tolcapone, a catechol-O-methyl transferase inhibitor, AM J MED, 108(6), 2000, pp. 517-518
SHV-type beta-lactamases
Authors: Tzouvelekis, LS Bonomo, RA
Citation: Ls. Tzouvelekis et Ra. Bonomo, SHV-type beta-lactamases, CUR PHARM D, 5(11), 1999, pp. 847-864
Emerging issues in antibiotic resistant infections in long-term care facilities
Authors: Bonomo, RA Rice, LB
Citation: Ra. Bonomo et Lb. Rice, Emerging issues in antibiotic resistant infections in long-term care facilities, J GERONT A, 54(6), 1999, pp. B260-B267
OHIO-1 beta-lactamase mutants: the Arg(244)Ser mutant and resistance to beta-lactams and beta-lactamase inhibitors
Authors: Lin, S Thomas, M Mark, S Anderson, V Bonomo, RA
Citation: S. Lin et al., OHIO-1 beta-lactamase mutants: the Arg(244)Ser mutant and resistance to beta-lactams and beta-lactamase inhibitors, BBA-PROT ST, 1432(1), 1999, pp. 125-136
Structure of the SHV-1 beta-lactamase
Authors: Kuzin, AP Nukaga, M Nukaga, Y Hujer, AM Bonomo, RA Knox, JR
Citation: Ap. Kuzin et al., Structure of the SHV-1 beta-lactamase, BIOCHEM, 38(18), 1999, pp. 5720-5727
Risultati: 1-17 |